| Medical Spine & Injury Center | |
|
8346 Kelwood Ave, Baton Rouge, LA 70806-4803 | |
| (225) 400-9004 | |
| (225) 810-3111 |
| Full Name | Medical Spine & Injury Center |
|---|---|
| Type | Facility |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 8346 Kelwood Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801233879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111NS0005X | Chiropractor - Sports Physician | (* (Not Available)) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Medical Spine & Injury Center 8346 Kelwood Ave, Baton Rouge, LA 70806-4803 Ph: (225) 400-9004 | Medical Spine & Injury Center 8346 Kelwood Ave, Baton Rouge, LA 70806-4803 Ph: (225) 400-9004 |
News Archive
Proteus Biomedical Inc., a pioneer in intelligent medicine, entered into an exclusive worldwide license and collaboration agreement with Novartis to develop and commercialize pharmaceutical products that incorporate Proteus' novel sensor-based technologies in the field of organ transplantation.
The cost estimate from the Congressional Budget Office takes into account lower-than-projected enrollment this year. Meanwhile, Oregon's Democratic senators ask the Government Accountability Office to examine federal funding of that state's website a day after House Republicans make a similar request.
A protein called ROBO1 may delay the progression of breast cancer, according to a paper published in The Journal of Cell Biology. The study, "Loss of miR-203 regulates cell shape and matrix adhesion through ROBO1/Rac/FAK in response to stiffness" by Lily Thao-Nhi Le and colleagues, identifies a signaling pathway that may protect breast cells from the tumorigenic effects of stiff extracellular matrices.
A new non-neurotoxic treatment for head lice has been found to have an average of 91.2% treatment success rate after one week, and to be safe in humans from six months of age and up. This is the finding of a study published today in Pediatric Dermatology.
Mitt Romney doesn't really want to talk about "RomneyCare," the universal health care plan he signed into law as Massachusetts governor.
› Verified 5 days ago